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Health data has long been scrutinised in relation to data quality and integrity problems. Currently, no
internationally accepted or "gold standard" method exists measuring data quality and error rates within
datasets. We conducted a source data verification (SDV) audit on a prospective clinical trial dataset. An audit
plan was applied to conduct 100% manual verification checks on a 10% random sample of participant files. A
quality assurance rule was developed, whereby if >5% of data variables were incorrect a second 10% random
sample would be extracted from the trial data set. Error was coded: correct, incorrect (valid or invalid), not
recorded or not entered. Audit-1 had a total error of 33% and audit-2 36%. The physiological section was the
only audit section to have <5% error. Data not recorded to case report forms had the greatest impact on error
calculations. A significant association (p=0.00) was found between audit-1 and audit-2 and whether or not
data was deemed correct or incorrect. Our study developed a straightforward method to perform a SDV audit.
An audit rule was identified and error coding was implemented. Findings demonstrate that monitoring data
quality by a SDV audit can identify data quality and integrity issues within clinical research settings allowing
quality improvement to be made. The authors suggest this approach be implemented for future research.
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Abstract. Health data has long been scrutinised in relation to data quality and 
integrity problems. Currently, no internationally accepted or “gold standard” 
method exists measuring data quality and error rates within datasets. We 
conducted a source data verification (SDV) audit on a prospective clinical trial 
dataset. An audit plan was applied to conduct 100% manual verification checks on 
a 10% random sample of participant files. A quality assurance rule was developed, 
whereby if >5% of data variables were incorrect a second 10% random sample 
would be extracted from the trial data set. Error was coded: correct, incorrect 
(valid or invalid), not recorded or not entered. Audit-1 had a total error of 33% and 
audit-2 36%. The physiological section was the only audit section to have <5% 
error. Data not recorded to case report forms had the greatest impact on error 
calculations. A significant association (p=0.00) was found between audit-1 and 
audit-2 and whether or not data was deemed correct or incorrect. Our study 
developed a straightforward method to perform a SDV audit. An audit rule was 
identified and error coding was implemented. Findings demonstrate that 
monitoring data quality by a SDV audit can identify data quality and integrity 
issues within clinical research settings allowing quality improvement to be made. 
The authors suggest this approach be implemented for future research. 
Keywords. Source data verification, data quality, quality assurance, clinical trial 
Introduction 
High quality data and effective data evaluation are crucial within clinical research as 
conclusions and recommendations rely largely on the outcomes of data. It is estimated 
an average of 976 errors (~10%) per 10 000 data points exist from transfer of source 
data to electronic data records [1,2]. Health data has long been scrutinised in relation to 
data quality and integrity problems [3,4]. To ensure data quality is an integral 
component of clinical trials best practice recommends personnel training, standard 
operating procedures (SOPs), and data monitoring are required to avoid scientific 
misconduct and assure compliance with the International Conference on Harmonisation 
(ICH) Good Clinical Practice (GCP) guidelines [5].  
Currently no internationally accepted or “gold standard” method exists to measure 
data quality and error rates within datasets. Dissimilarities between methods make it 
difficult to determine “acceptable” data quality. Data entry errors may introduce bias 
risking misleading and/or false results [2,6]. Multiple issues such as error type, extent 
and variables where errors are found, play an important role in the statistical analyses 
T
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in determining data quality [7]. Through the use of routine verification checks, 
transcription errors can be detected [8]. 
Auditing is a recognised method used for centuries to assess and develop the 
quality of products, services and information [9-11]. An auditor’s role is to validate 
data collected on source documents against data entered into electronic records and/or 
databases. Medical audits are employed to detect and evaluate patient care, services and 
documented discrepancies [12,13]. Quality assurance audits within clinical settings are 
an extensively used process recognised to ensure high quality data is produced 
[1,2,7,14-16]. Many organisations collect and analyse data for the benefit of their own 
research for quality control and SOPs. Unpublished audit methods and their subsequent 
results leave a gap within the published literature. 
Source data verification (SDV) is the process of comparing source data (original or 
certified copy) documents to data recorded or entered to a case report form (CRF), 
electronic record or database. Data integrity can be ensured through different data 
monitoring techniques, including logic, consistency and range checks, which are useful 
for determining major errors that are “out-of-the-ordinary”. SDV is considered a more 
accurate method, because it identifies all major and minor errors. Minor errors may 
seem insignificant, however, consistent minor errors add up and potentially lead to low 
quality data. Therefore, the aim of this research was to monitor data quality through the 
use of SDV audits to ensure data integrity within a clinical research setting. 
1. Methods 
1.1. Planning and Procedure of Data Audit 
A SDV audit was performed on baseline data of a prospective clinical trial dataset to 
determine data quality. Audits occurred between September 2014 and February 2015 at 
the University of Wollongong and the Illawarra Health and Medical Research Institute 
(IHMRI). One auditor conducted the audit to ensure consistency. Consensus with the 
research team on points of uncertainty was conducted prior to commencing.  
Paper, handwritten CRFs were used as the source document to collect and store 
participant information during trial consultations. A team of five clinical Accredited 
Practising Dietitians transcribed data from CRFs into an electronic spreadsheet record 
(ESR). To limit bias the SDV audit was blinded from the participating clinical 
dietitians. A pre-test, post-test style of audit was applied across this research related to 
a quality improvement framework.  
An audit plan was applied to conduct 100% manual verification checks on a 10% 
random sample of participant files. Verification of original source documents was 
conducted to determine data quality [17]. During audits, comparison between source 
documents to data listings entered into the ESR were made. A quality assurance rule 
was developed, whereby if >5% of data variables were incorrect a second 10% random 
sample (excluding files already sampled) would be extracted from the data set. A 
researcher independent of the SDV extracted a 10% random sample of enrolled study 
participants using SPSS software (version 22 2013, IBM Australia, Lane Cove, NSW, 
Australia). This approach was based on a monitoring plan by the Acute Respiratory 
Distress Syndrome (ARDS) network, a National Institute of Health-sponsored clinical 
trial [1], where a 10% random sample of participants were extracted for review to 
confirm eligibility and validation of all erroneous data point incidents. 
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For audit-1 conducted on 1st October 2014, 21 files containing CRFs were 
extracted from filing cabinets and scanned. A snapshot of the data was taken the same 
day CRFs were scanned to ensure no changes were made to the ESR during the audit 
period reducing the risk of introduced bias. The audit was segmented into three 
relevant sections: anthropometric, physiological and medication data. Sections were 
determined in relation to the relevant source documents and time-points used for data 
collection. Each individual data point recorded in the CRF of the above sections was 
considered. Audit outcomes were coded and recorded into a separate ESR for analysis. 
Due to audit-1 findings (>5% error rate) in two of three sections, audit-2 was 
completed on anthropometric and medication data only. Audit-2 commenced on 15th 
December 2014 and the same procedure for audit-1 was applied. Participants included 
in audit-1 were excluded from audit-2. Recommendations for continuous quality 
improvement (CQI) within the context of each dataset were made to ensure future data 
integrity during the trial.  
1.2. Error Classification 
During the audit process, data points were categorised using standard audit codes 
derived from the European Organisation for the Research and Treatment of Cancer 
(EORTC) [18]. Audited data was coded: Correct (code 1) – Data values entered to the 
ESR match the values recorded on CRF; Valid incorrect (code 2) – Minor error 
discrepancies where data had been transcribed incorrectly but had no direct impact on 
the studies outcome. E.g. values incorrectly rounded to the nearest integer, values 
entered incorrectly which fell within a predetermined range or incorrectly spelt 
medications; Invalid incorrect (code 3) – Major errors discrepancies were data that had 
been transcribed incorrectly that the auditor considered clinically significant. E.g. 
Missing documents or values entered incorrectly which fell outside a predetermined 
range; Not recorded (code 4) – Data not recorded on CRF but values exist in ESR; Not 
entered (code 5) – Data recorded on CRF however had been missed and left blank 
when entered to ESR. 
1.3. Statistical Analysis 
To examine data quality and integrity, the total error rate was calculated by dividing 
erroneous data points (code 2,3,4) by total data points (code 1,2,3,4). Data not entered 
was excluded from the error calculation, as data not entered was not deemed incorrect. 
Chi square analyses were used to examine any potential associations between audit-1 
and audit-2 and whether data was correct or incorrect.  
Data was analysed using SPSS (version 22) statistical analysis software. Statistical 
significance was set at p<0.05. This study was approved by the University of 
Wollongong Human Research Ethics Committee. 
2. Results 
A total of 42 randomly selected participant CRFs were extracted for audit-1 (n=21) and 
audit-2 (n=21). A total of 1505 data points were audited, 958 correct, 20 valid incorrect, 
55 invalid incorrect, 260 not recorded and 212 not entered. Of the 212 data points not 
entered, 44% were from the anthropometric, 1% physiological and 55% medications 
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data sections of the two audits. Both audit-1 and 2, not recorded data had the greatest 
contribution to total error rate, 33% and 44%, respectively. Table 1 shows the number 
of variables audited at audit-1 and 2 and error rate for each section.  
 
 
Table 1. Audited sections and the percent of erroneous data during audit-1 and 2 for each section. 
 Audit-1 Audit-2 
Audit section Na NErrb % Errc N Nerr %Err 
Anthropometric 275 13 6 409 46 13 
Physiologicald 341 0 0 - - - 
Medicines 204 112 75 276 164 77 
Total 640 125 17 685 210 36 
Err: Error 
a Count of data points (N) (code 1,2,3,4,5) 
b Count of data erroneous data (Nerr) (code 2,3,4) 
c Percent of erroneous data (code 2,3,4 divided by code 1,2,3,4,) 
d Physiological audit section did not complete audit-2 due to QA rule (<5% error rate from audit-1) 
 
 
Error rates ranged from 0-77% within the three audited sections. All audited data 
records within the physiological section were correct, therefore, the error was <5%, a 
second audit was not deemed necessary. Anthropometric data error more than doubled, 
increasing by 7% and medications data error increased by 2%. The medications section 
had the largest error >75%. Total error more than doubled (17% versus 36%) when 
comparing audits. Audit-1 and 2 had similar error rates when the physiological data 
section was excluded, with 33% and 36% error rate, respectively. Exclusion of 
physiological data from audit-1 increased overall error by 16%.  
Chi squared analysis results found significant association between audit-1 and 
audit-2 and whether or not data was correct or incorrect: χ2 (4, 1293) = 672.405, p = 
0.00. The proportion of correct audit-1 data was significantly related to the proportion 
of correct audit-2 data. According to these results, 74% of data was deemed correct and 
26% was deemed incorrect when combing the results of audit-1 and audit-2. 
3. Discussion 
Limited published literature exists on the method used for SDV audits and the success 
of detecting systematic and random errors. Our study developed and applied a 
straightforward method to perform a SDV audit. An audit rule was identified and error 
coding was implemented, a process easy to replicate for future research. The error 
classification method for coding data is consistent with other studies [1,18,19]. 
Examining the heterogeneity of error coding and what the literature classifies as an 
error differs. A definition to determine data quality and error within published literature 
is warranted.  
Our finding that >30% of total error in both audits indicates the importance of a 
SDV audit for identifying error. The proportion of error trended upward as length of 
study increased, which is consistent with the Duke Clinical Research Institute [7]. 
L. Houston et al. / Measuring Data Quality Through a Source Data Verification Audit110
However, completing multiple audits throughout the length of the study and providing 
CQI can improve data quality and integrity. It is accepted in published literature that if 
>10% of a dataset is erroneous, the data be considered unreliable [20]. A 5% quality 
assurance rule was selected within this research setting. This study had five data entry 
personnel and a relatively small dataset conducted at a single-site, therefore, 
expectations for quality of data was high. Within audit-1 physiological data was the 
only section to have an error rate <5%, as data for this section was electronically 
generated; therefore, not recorded data had no impact on error calculation. 
Anthropometric and medicines data sections increased in error recording a total error 
>10% for audit-2. Greater error rate could be due to data obtained through ‘participant 
recall’, which is subjective to communication and memory.  
In tightly regulated prospective clinical trials most databases have a lower 
acceptance criteria of 0.5% error [7]. However, in a clinical research setting, the 
average error rate of a source-to-database audit is roughly 10% [1,19]. Duda et al. [19] 
reported on having an error >10% ranging from 2% to 34% across seven different audit 
sites. Similarly, the EROTC study [18] found across 15 centers correct data ranged 
from 78-98% finding data quality was influenced by training and knowledge of data 
management and those entering data. In comparison to findings in this study, the 
percentage of error ranged within different data sections of the audit and an increase in 
error could be due to five different personnel reporting, recording and entering data. 
Conflicting with previous research Nahm, Pieper and Cunningham [2] took a holistic 
approach to assess data quality and found a significant decrease of 4% when verifying 
source-to-database. Within the literature, there are inconsistent findings regarding 
“acceptable” error rates. Therefore, a standardised method for SDV audits needs to be 
recognised.  
After reviewing the limited published literature we believe a 5% error rate within 
electronic datasets should be the “gold standard” for determining data quality within a 
clinical setting and believe a 10% error rate published within multiple studies is too 
large to draw on reliable and valid results. Errors vary depending on the type of dataset, 
and a 10% error rate may be more acceptable for manually transcribed data.  
This study’s results are limited to the University of Wollongong and IHMRI and 
development of clinical trial operations. Audit results are subject to variations in 
procedure and disclaimer of trials design. Audits results presented here are limited to 
source-to-ESR audits and from the authors’ understanding this is the first of it’s kind 
within published literature. Based on our experience with an audit methodology and 
rule, the use of different error coding and variations in method design for calculating 
error rates vary widely across the industry. One auditor completed the audit process 
and results are limited to their knowledge and critique. Knowledge and experience was 
gained throughout the audit process. Hence, audit-2 may be more likely to uncover 
errors when compared to audit-1. Only a 10% random sample of participant records 
was audited and a true error rate may differ from the estimated error rate reported in 
this paper.  
The SDV audit allowed for identification of weaknesses within the data recording, 
collection and storing process and how these can be resolved before erroneous data can 
cause problems within results. It is recommended a CQI cycle framework is developed 
to plan, do, check and act on erroneous data points. Conducting an educational training 
workshop focusing on the importance of data collection and entry highlights the 
significance of data quality to data entry personnel, and research team. Standardised 
procedures are required to structure CRFs to ensure consistent documentation is 
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produced. Double-checking and revising 100% of data points entered to the ESR before 
a third SDV audit aims to maximise quality assurance. Future research should focus on 
implementing a more standardised method of SDV audits.  
4. Conclusion  
The findings of this study demonstrate that monitoring data quality through the use of a 
SDV audit can identify data quality and integrity issues within a clinical research 
setting. The study has developed a simple yet effective method that can be employed to 
determine error within a dataset. This can be applied not only to clinical research but 
also to all data quality assurance studies.  
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